K. R. Bogaard

Publications

153

Citations

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

K. R. Bogaard is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, clinical trials, and cancer therapeutics.

Top concepts

HealthMedicineOncologyPharmacologyCancer TherapyCancer ResearchClinical TrialsPharmacotherapyColorectal CancerMolecular Oncology

Publications per year

2006–2006

Publications

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors

David S. Hong, James L. Abbruzzese, K. R. Bogaard et al. · Cancer · 2006 · 86 citations

A Phase I Study of Escalating Doses of the Tyrosine Kinase Inhibitor Semaxanib (SU5416) in Combination with Irinotecan in Patients with Advanced Colorectal Carcinoma

Paulo M. Hoff, Robert A. Wolff, K. R. Bogaard et al. · Japanese Journal of Clinical Oncology · 2006 · 35 citations · Full text

Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC)

Scott Kopetz, James L. Abbruzzese, Cathy Eng et al. · Journal of Clinical Oncology · 2006 · 22 citations

Phase Ii Study, Pharmacotherapy, Pre-clinical Pharmacology +19

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

Paulo M. Hoff, Robert A. Wolff, Henry Xiong et al. · Cancer · 2006 · 10 citations

Rows per page

1–4 of 4